The forecast for government expenditures on R&D in health in France shows a modest upward trend from 2024 to 2028, with values increasing from $3.04 billion to $3.10 billion US dollars PPP. This indicates a gradual annual growth with a slight increase each year. Given that the 2023 value is not specified, the precise base for these increments remains unclear. However, the steady rise reflects ongoing commitments to R&D in health.

Future trends to watch for include:

Potential policy shifts impacting R&D funding levels.
Inflationary pressures that might affect real purchasing power for R&D investments.
Technological advancements catalyzing more significant investments.